213
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Amide-Linked Monocarbonyl Curcumin Analogues: Efficient Synthesis, Antitubercular Activity and Molecular Docking Study

, , , , , & show all
Pages 2655-2671 | Received 14 Sep 2020, Accepted 25 Oct 2020, Published online: 09 Dec 2020

References

  • R. Rappuoli, “Changing Route: Aerosol Vaccine against Tuberculosis,” The Lancet Infectious Diseases 14, no. 10 (2014): 901–2.
  • “Global Tuberculosis Report.” http://www.who.int/tb/publications/global_report/en/.
  • B. D. Kana, P. C. Karakousis, T. Parish, and T. Dick, “Future Target-Based Drug Discovery for Tuberculosis?,” Tuberculosis (Edinburgh, Scotland) 94, no. 6 (2014): 551–6.
  • S. A. Noureddin, R. M. El-Shishtawy, and K. O. Al-Footy, “Curcumin Analogues and Their Hybrid Molecules as Multifunctional Drugs,” European Journal of Medicinal Chemistry 182, (2019): 111631.
  • T. P. Robinson, T. Ehlers, R. B. Hubbard Iv, X. Bai, J. L. Arbiser, D. J. Goldsmith, and J. P. Bowen, “Design, Synthesis, and Biological Evaluation of Angiogenesis Inhibitors: Aromatic Enone and Dienone Analogues of curcumin,” Bioorganic & Medicinal Chemistry Letters 13, no. 1 (2003): 115–7.
  • H. Ohtsu, Z. Xiao, J. Ishida, M. Nagai, H.-K. Wang, H. Itokawa, C.-Y. Su, C. Shih, T. Chiang, E. Chang, et al. “Antitumor Agents. 217. Curcumin Analogues as Novel Androgen Receptor Antagonists with Potential as anti-Prostate Cancer Agents,” Journal of Medicinal Chemistry 45, no. 23 (2002): 5037–42.
  • K. Bairwa, J. Grover, M. Kania, and S. M. Jachak, “Recent Developments in Chemistry and Biology of Curcumin Analogues,”RSC Advances 4, no. 27 (2014): 13946–78; and references cited therein.
  • A. Tiwari, S. Kumar, R. Shivahare, P. Kant, S. Gupta, and S. N. Suryawanshi, “Chemotherapy of Leishmaniasis Part XIII: Design and Synthesis of Novel Heteroretinoid-Bisbenzylidine Ketone Hybrids as Antileishmanial Agents,” Bioorganic & Medicinal Chemistry Letters 25, no. 2 (2015): 410–3.
  • S. F. P. Braga, E. V. P. Alves, R. S. Ferreira, J. R. B. Fradico, P. S. Lage, M. C. Duarte, T. G. Ribeiro, P. A. S. Junior, A. J. Romanha, M. L. Tonini, et al. “Synthesis and Evaluation of the Antiparasitic Activity of Bis-(Arylmethylidene) Cycloalkanones,” European Journal of Medicinal Chemistry 71 (2014): 282–9.
  • P. Yu, L. Dong, Y. Zhang, W. Chen, S. Xu, Z. Wang, X. Shan, J. Zhou, Z. Liu, and G. Liang, “Design, Synthesis and Biological Activity of Novel Asymmetric C66 Analogs as anti-Inflammatory Agents for the Treatment of Acute Lung Injury,” European Journal of Medicinal Chemistry 94 (2015): 436–46.
  • T. Kalai, M. L. Kuppusamy, M. Balog, K. Selvendiran, B. K. Rivera, P. Kuppusamy, and K. Hideg, “Synthesis of N-Substituted 3,5-Bis(arylidene)-4-piperidones with High Antitumor and Antioxidant Activity,” Journal of Medicinal Chemistry 54, no. 15 (2011): 5414–21.
  • S. Y. Chen, Y. Chen, Y. P. Li, S. H. Chen, J. H. Tan, T. M. Ou, L. Q. Gu, and Z. S. Huang, “Design, Synthesis, and Biological Evaluation of Curcumin Analogues as Multifunctional Agents for the Treatment of Alzheimer's disease,” Bioorganic & Medicinal Chemistry 19, no. 18 (2011): 5596–604.
  • S. Kaur, N. H. Modi, D. Panda, and N. Roy, “Probing the Binding Site of Curcumin in Escherichia coli and Bacillus subtilis FtsZ-A Structural Insight to Unveil Antibacterial Activity of Curcumin,” European Journal of Medicinal Chemistry 45, no. 9 (2010): 4209–14.
  • K. Kandi, S. Manohar, C. E. Gerena, B. Zayas, S. V. Malhotra, and D. S. Rawat, “C5-Curcuminoid-4-Aminoquinoline Based Molecular Hybrids: Design, Synthesis and Mechanistic Investigation of Anticancer Activity,” New Journal of Chemistry 39, no. 1 (2015): 224–34.
  • P. R. Baldwin, A. Z. Reeves, K. R. Powell, R. J. Napier, A. I. Swimm, A. Sun, K. Giesler, B. Bommarius, T. M. Shinnick, J. P. Snyder, et al., “Monocarbonyl Analogs of Curcumin Inhibit Growth of Antibiotic Sensitive and Resistant Strains of Mycobacterium tuberculosis,” European Journal of Medicinal Chemistry 92 (2015): 693–9; (b) N. Singh, J. Pandey, A. Yadav, V. Chaturvedi, S. Bhatnagar, A. N. Gaikwad, S. K. Sinha, A. Kumar, P. K. Shukla, and R. P. Tripathi, “A Facile Synthesis of Alpha,alpha’-(EE)-bis(benzylidene)-Cycloalkanones and Their Antitubercular Evaluations,” European Journal of Medicinal Chemistry 44 (2009): 1705–9; (c) U. Das, S. Das, B. Bandy, J. P. Stablesb, and J. R. Dimmoc, “N-Aroyl-3,5-Bis(benzylidene)-4-Piperidones: A Novel Class of Antimycobacterial Agents,” Bioorganic & Medicinal Chemistry 16 (2008): 3602–7.
  • Methods for the synthesis of curcumin analogues see: (a) S. A. Noureddin, R. M. El-Shishtawy, and K. O. Al-Footy, “Synthesis of New Symmetric Cyclic and Acyclic Halocurcumin Analogues Typical Precursors for Hybridization,” Research on Chemical Intermediates 46 (2020): 5307–5323; (b) H. Lin, G. X. Hua, J. Guo, Y. Ge, G. Liang, Q. Q. Lian, Y. Chu, X. Yuan, P. Huang, and R. S. Ge, “Mono-Carbonyl Curcumin Analogues as 11β-Hydroxysteroid Dehydrogenase 1 Inhibitors,” Bioorganic & Medicinal Chemistry Letters 23 (2013): 4362–6; (c) X. Yuan, H. Li, H. Bai, Z. Su, Q. Xiang, C. Wang, B. Zhao, Y. Zhang, Q. Zhang, Y. Chu, et al., “Synthesis of Novel Curcumin Analogues for Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 with Anti-Diabetic Properties,” European Journal of Medicinal Chemistry 77 (2014): 223–30; (d) I. M. Fawzy, K. M. Youssef, N. S. M. Ismail, J. Gullbo, and K. A. M. Abouzid, “Design and Synthesis and Biological Evaluation of Novel Curcumin Analogs with Anticipated Anticancer Activity,” Future Journal of Pharmaceutical Sciences 1 (2015): 22; (e) N. K. Paul, M. Jha, K. S. Bhullar, H. P. V. Rupasinghe, J. Balzarini, and A. Jha, “All Trans 1-(3-arylacryloyl)-3,5-bis(pyridin-4-ylmethylene)piperidin-4-ones as Curcumin-Inspired Antineoplastics,” European Journal of Medicinal Chemistry 87 (2014): 461–70; (f) A. Tiwari, S. Kumar, R. Shivahare, P. Kant, S. Gupta, and S. N. Suryawanshi, “Chemotherapy of leishmaniasis part XIII: Design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents,” Bioorganic & Medicinal Chemistry Letters 25 (2015): 410; (g) M. V. Makarov, E. S. Leonova, E. Y. Rybalkina, P. Tongwa, V. N. Khrustalev, T. V. Timofeeva, and I. L. Odinets, “Synthesis, Characterization and Structure-Activity Relationship of Novel N-Phosphorylated E,E-3,5-bis(thienylidene)piperid-4-ones,” European Journal of Medicinal Chemistry 45 (2010): 992–1000.
  • (a) P. Wasserscheid, and T. Welton, Eds. (Weinheim, Germany: Wiley-VCH, Verlag GmbH & Co., 2002); (b) C. Yue, D. Fang, L. Liu, and T. F. Yi, “Synthesis and Application of Task-Specific Ionic Liquids Used as Catalysts and/or Solvents in Organic Unit Reactions,” Journal of Molecular Liquids 163 (2011): 99–121.
  • N. Samaan, Q. Zhong, J. Fernandez, G. Chen, A. M. Hussain, S. Zheng, G. Wang, and Q. H. Chen, “Design, Synthesis, and Evaluation of Novel Heteroaromatic Analogs of Curcumin as anti-Cancer Agents,” European Journal of Medicinal Chemistry 75 (2014): 123–31.
  • C. Wang, W. Zhao, H. Li, and L. Guo, “Solvent-Free Synthesis of Unsaturated Ketones by the Saucy–Marbet Reaction Using Simple Ammonium Ionic Liquid as a Catalyst,” Green Chemistry 11, no. 6 (2009): 843–7.
  • R. C. Cioc, E. Ruijter, and R. V. A. Orru, “Multicomponent Reactions: Advanced Tools for Sustainable Organic Synthesis,” Green Chemistry 16, no. 6 (2014): 2958–75.
  • N. Isambert, M. M. S. Duque, J. C. Plaquevent, Y. Genisson, J. Rodriguez, and T. Constantieux, “Multicomponent Reactions and Ionic Liquids: A Perfect Synergy for Eco-Compatible Heterocyclic Synthesis,” Chemical Society Reviews 40, no. 3 (2011): 1347–57.
  • (a) D. D. Subhedar, M. H. Shaikh, L. Nawale, A. Yeware, D. Sarkar, and B. B. Shingate, “[Et3NH][HSO4] Catalyzed Efficient Synthesis of 5-Arylidene-Rhodanine Conjugates and Their Antitubercular Activity,” Research on Chemical Intermediates 42 (2016): 6607–26; (b) D. D. Subhedar, M. H. Shaikh, L. Nawale, A. Yeware, D. Sarkar, F. A. K. Khan, J. N. Sangshetti, and B. B. Shingate, “Novel Tetrazoloquinoline-Rhodanine Conjugates: Highly Efficient Synthesis and Biological Evaluation,” Bioorganic & Medicinal Chemistry Letters 26 (2016): 2278–83; (c) M. H. Shaikh, D. D. Subhedar, F. A. K. Khan, J. N. Sangshetti, and B. B. Shingate, “[Et3NH][HSO4]-Catalyzed One-Pot, Solvent-Free Synthesis and Biological Evaluation of α-Amino Phosphonates,” Research on Chemical Intermediates 42 (2016): 5115–31; (d) D. D. Subhedar, M. H. Shaikh, M. Arkile, A. Yeware, D. Sarkar, and B. B. Shingate, Bioorganic & Medicinal Chemistry Letters 26 (2016): 1704; (e) A. A. Nagargoje, S. V. Akolkar, and M. M. Siddiqui, “Synthesis and Evaluation of Pyrazole Incorporated Monocarbonyl Curcumin Analogues as Antiproliferative and Antioxidant Agents,” Journal of the Chinese Chemical Society 66 (2019): 1658–65; (f) A. A. Nagargoje, S. V. Akolkar, and D. D. Subhedar, “Propargylated Monocarbonyl Curcumin Analogues: Synthesis, Bioevaluation and Molecular Docking Study,” Medicinal Chemistry Research 29 (2020): 1902–13.
  • J. Weng, C. Wang, H. Li, and Y. Wang, “Novel Quaternary Ammonium Ionic Liquids and Their Use as Dual Solvent-Catalysts in the Hydrolytic Reaction,” Green Chemistry 8, no. 1 (2006): 96–9.
  • Z. N. Siddiqui, and K. Khan, “[Et3NH][HSO4]-Catalyzed Efficient, Eco-Friendly, and Sustainable Synthesis of Quinoline Derivatives via Knoevenagel Condensation,” ACS Sustainable Chemistry & Engineering 2, no. 5 (2014): 1187–94; and references cited therein.
  • A. Khan, S. Sarkar, and D. Sarkar, “Bactericidal Activity of 2-Nitroimidazole against the Active Replicating Stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with Intracellular Efficacy in THP-1 Macrophages,” International Journal of Antimicrobial Agents 32, no. 1 (2008): 40–5.
  • R. C. Hartkoorn, B. Chandler, A. Owen, S. A. Ward, S. Bertel Squire, D. J. Back, and S. H. Khoo, “Differential Drug Susceptibility of Intracellular and Extracellular Tuberculosis, and the Impact of P-Glycoprotein,” Tuberculosis 87, no. 3 (2007): 248–55.
  • S. T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry, et al. “Deciphering the Biology of Mycobacterium tuberculosis from the Complete Genome Sequence,” Nature 393, no. 6685 (1998): 537–44.
  • D. Sreekanth, A. Syed, S. Sarkar, D. Sarkar, B. Santhakumari, A. Ahmad, and I. Khan, “Production, Purification and Characterization of Taxol and 10DAB III from a New Endophytic Fungus Gliocladium sp. isolated from the Indian Yew Tree,” Journal of Microbiology and Biotechnology 19 (2009): 1342–7.
  • L. L. Gundersen, J. N. Meyer, and B. Spilsberg, “Synthesis and Antimycobacterial Activity of 6-Arylpurines: The Requirements for the N-9 Substituent in Active Antimycobacterial Purines,”Journal of Medicinal Chemistry 45, no. 6 (2002): 1383–6.
  • R. Singh, L. U. Nawale, M. Arkile, U. U. Shedbalkar, S. A. Wadhwani, D. Sarkar, and B. A. Chopade, “Chemical and Biological Metal Nanoparticles as Antimycobacterial Agents: A Comparative Study,” International Journal of Antimicrobial Agents 46, no. 2 (2015): 183–8.
  • Glide (version 5.8) (New York, NY: Schrodinger, LLC, 2012).
  • Maestro (version 9.3) (New York, NY: Schrodinger, LLC, 2012).
  • LigPrep (version 2.5) (New York, NY: Schrodinger, LLC, 2012).
  • Prime (version 3.1) (New York, NY: Schrodinger, LLC, 2012).
  • R. A. Friesner, J. L. Banks, R. B. Murphy, T. A. Halgren, J. J. Klicic, D. T. Mainz, M. P. Repasky, E. H. Knoll, M. Shelley, J. K. Perry, et al. “Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy,” Journal of Medicinal Chemistry 47, no. 7 (2004): 1739–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.